These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2483564)

  • 41. Protection of arterial and arteriolar wall structure by specific calcium antagonists.
    Frey M; Zorn J; Fleckenstein A; Fleckenstein-Grün G
    Ann N Y Acad Sci; 1988; 522():420-32. PubMed ID: 3377374
    [No Abstract]   [Full Text] [Related]  

  • 42. Arterial blood pressure and stiffness in hypertension: is arterial structure important?
    Payne RA; Webb DJ
    Hypertension; 2006 Sep; 48(3):366-7. PubMed ID: 16908759
    [No Abstract]   [Full Text] [Related]  

  • 43. [The treatment of arterial hypertension].
    de la Figuera M
    Aten Primaria; 1993 Feb; 11(3):155. PubMed ID: 8453010
    [No Abstract]   [Full Text] [Related]  

  • 44. Do calcium antagonists correct a pathophysiological abnormality in hypertension?
    Bühler FR; Cauvin C; Blaustein MP; Hermsmeyer K; Robinson BF
    J Cardiovasc Pharmacol; 1988; 12 Suppl 6():S1-2. PubMed ID: 2468886
    [No Abstract]   [Full Text] [Related]  

  • 45. Calcium channel blockers to counter hypertension.
    Miller CA
    Geriatr Nurs; 1991; 12(5):259. PubMed ID: 1667180
    [No Abstract]   [Full Text] [Related]  

  • 46. Assessment of arterial compliance in hypertension.
    McVeigh GE; Finkelstein SM; Cohn JN
    Curr Opin Nephrol Hypertens; 1993 Jan; 2(1):82-6. PubMed ID: 7922172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calcium channel blockade for patient-oriented therapy of systemic hypertension.
    Parmley WW
    Am J Cardiol; 1986 Sep; 58(8):39D-40D. PubMed ID: 3766408
    [No Abstract]   [Full Text] [Related]  

  • 48. Calcium, calcium antagonism, and structural changes in hypertension. Satellite symposium to the 5th ESH meeting. Milan, June 7, 1991.
    J Cardiovasc Pharmacol; 1992; 19 Suppl 2():S1-62. PubMed ID: 1377298
    [No Abstract]   [Full Text] [Related]  

  • 49. [Arterial compliance or elasticity?].
    Meyerheine A; Ansquer JC; Lagrue G
    Presse Med; 1988 Feb; 17(6):283. PubMed ID: 2964630
    [No Abstract]   [Full Text] [Related]  

  • 50. Arterial stiffness and hypertension: a two-way street?
    Franklin SS
    Hypertension; 2005 Mar; 45(3):349-51. PubMed ID: 15710783
    [No Abstract]   [Full Text] [Related]  

  • 51. Overcoming Confounding to Characterize the Effects of Calcium Channel Blockers.
    Rajagopal S; Rosenberg PB
    Function (Oxf); 2023; 4(6):zqad054. PubMed ID: 37841524
    [No Abstract]   [Full Text] [Related]  

  • 52. The measurement of arterial properties in hypertension.
    Weber MA
    Am J Hypertens; 2001 Feb; 14(2):183-5. PubMed ID: 11243311
    [No Abstract]   [Full Text] [Related]  

  • 53. [Arterial hypertension in the systemic circulation and in local circulations. Treatment with protistotherapy].
    MEGIAS J
    Medicina (Madr); 1963 May; 31():201-32. PubMed ID: 13934470
    [No Abstract]   [Full Text] [Related]  

  • 54. [News from the conference of arterial hypertension, Praga, 2002].
    Karpov IuA
    Kardiologiia; 2002; 42(12):67-9. PubMed ID: 12494024
    [No Abstract]   [Full Text] [Related]  

  • 55. An Open Label Parallel Group Study to Assess the Effects of Amlodipine and Cilnidipine on Pulse Wave Velocity and Augmentation Pressures in Mild to Moderate Essential Hypertensive Patients.
    Pathapati RM; Rajashekar ST; Buchineni M; Meriga RK; Reddy CB; Kumar KP
    J Clin Diagn Res; 2015 Nov; 9(11):FC13-6. PubMed ID: 26676157
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contribution of transient and sustained calcium influx, and sensitization to depolarization-induced contractions of the intact mouse aorta.
    Fransen P; Van Hove CE; van Langen J; Schrijvers DM; Martinet W; De Meyer GR; Bult H
    BMC Physiol; 2012 Sep; 12():9. PubMed ID: 22943445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aortic pulse pressure is associated with the localization of coronary artery disease based on coronary flow lateralization.
    Khoueiry G; Azab B; Torbey E; Abi Rafeh N; Atallah JP; Ahern K; Malpeso J; McCord D; Chemaly ER
    Am J Hypertens; 2012 Oct; 25(10):1055-63. PubMed ID: 22739807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Simultaneous echocardiographic evaluation of coronary flow velocity reserve and aortic distensibility indices in hypertension.
    Nemes A; Forster T; Csanády M
    Heart Vessels; 2007 Mar; 22(2):73-8. PubMed ID: 17390200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Management of isolated systolic hypertension.
    Tonkin A; Wing L
    Drugs; 1996 May; 51(5):738-49. PubMed ID: 8861544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Elastic properties and Windkessel function of the human aorta.
    Belz GG
    Cardiovasc Drugs Ther; 1995 Feb; 9(1):73-83. PubMed ID: 7786838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.